Inhibition of human IgE production via Fc epsilon R-II stimulation results from a decrease in the mRNA for secreted

A Saxon1, M Kurbe-Leamer, K Behle

  • 1Hart and Louise Lyon Laboratory, Department of Medicine, UCLA School of Medicine 90024.

Insights

Inhibiting IgE production with Fc epsilon R-II (CD23) reduces specific mRNA for secreted IgE and lambda light chains. This suggests a post-transcriptional mechanism selectively affects secreted protein mRNA levels.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • The low-affinity Fc receptor for IgE (Fc epsilon R-II), also known as CD23, plays a role in regulating IgE production.
  • Previous studies demonstrated that Fc epsilon R-II can inhibit IgE secretion from human plasma cells.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying Fc epsilon R-II-mediated inhibition of IgE production.
  • To analyze changes in epsilon messenger RNA (mRNA) and lambda light chain mRNA during IgE suppression.

Main Methods:

  • Utilized a human plasma cell line (AF-10) and IgE-anti-IgE immune complexes or anti-CD23 monoclonal antibodies for inhibition studies.
  • Quantified epsilon mRNA species (2.1, 3.0, 3.8 kb) and lambda L chain mRNA using Northern blotting with a genomic probe for the human epsilon C region.
  • Measured membrane and secreted IgE and lambda protein levels.

Main Results:

  • Identified three epsilon mRNA species: 3.8 kb (full membrane sequence), 2.1 kb (secreted protein), and 3.0 kb (secreted protein with partial membrane sequence).
  • Fc epsilon R-II-mediated suppression of IgE production led to a 50% decrease in 2.1 kb and 3.0 kb epsilon mRNA, and a corresponding decrease in lambda mRNA and protein secretion.
  • Levels of membrane IgE protein and the mRNA encoding it remained unchanged.

Conclusions:

  • Inhibition of IgE production by Fc epsilon R-II (CD23) is associated with a reduction in mRNA for secreted forms of IgE and lambda light chains.
  • These findings suggest a post-transcriptional regulatory mechanism that selectively targets mRNA for secreted proteins, rather than membrane-bound proteins.